Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.39 |
| ▸ | CCNT1 | O60563 | 10/20 | 0.37 |
| ▸ | CDK9 | P50750 | 10/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5821626 | 0.92 | CCNT1 (0.42) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5823372 | 0.89 | KDM4E (0.43) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5824183 | 0.88 | CCNT1 (0.39) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5950590 | 0.86 | CDK9 (0.38) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5821180 | 0.84 | ABCB1 (0.36) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5950514 | 0.83 | HTR1A (0.40) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5950516 | 0.83 | HTR1A (0.40) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5822824 | 0.81 | CCNT1 (0.45) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5820172 | 0.81 | TLR9 (0.41) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5818162 | 0.81 | TLR9 (0.45) | KDM4EMEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060235037-A1 | Heterocyclic inhibitors of protein arginine methyl transferases | BRISTOL-MYERS SQUIBB COMPANY | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235037-A1 | Heterocyclic inhibitors of protein arginine methyl transferases | PRMT1, PRMT3, PRMT8 | KDM4E 646/4885MEN1 2684/4885ALDH1A1 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.